期刊文献+

转铁蛋白逆转血浆脂蛋白体外氧化修饰的研究

REVERSE EFFECT OF TRANSFERRIN ON THE OXIDATIVE MODIFICATION OF PLASMA LIPOPROTEIN INDUCED BY Cu^(2+) OR Fe^(2+) IN VITRO
下载PDF
导出
摘要 目的 :观察转铁蛋白 (Tf)对体外已受到Cu2 + 、Fe2 + 修饰的人血浆高密度脂蛋白 (HDL)、低密度脂蛋白(LDL)和极低密度脂蛋白 (VLDL)氧化修饰的影响。方法 :采用一次性密度梯度超离心法分离正常人血浆HDL、LDL和VLDL ,在 37℃分别与CuSO4 及FeSO4 温育 6小时 ,使脂蛋白在体外氧化修饰。转铁蛋白组在氧化修饰后加入4 0 0 μg ml的Tf作用 8小时。检测三种脂蛋白中脂质过氧化产物丙二醛 (MDA) ,维生素E(VitE)含量及超氧化物歧化酶 (SOD)活性。结果 :①HDL、LDL和VLDL与Cu2 + 或Fe2 + 温育后 ,MDA含量显著升高 (P <0 .0 0 1) ,并呈明显的时间效应。②在Cu2 + 或Fe2 + 修饰后加入 4 0 0 μg ml的Tf能使明显降低HDL、LDL和VLDL中MDA生成 ,阻止VitE含量下降 ,并显著提高SOD活性 ,呈现一定的浓度依赖性。结论 :结果提示Tf能显著逆转Cu2 + 或Fe2 + 介导的血浆HDL、LDL和VLDL氧化修饰 ,可能为一内源性抗动脉粥样硬化因子。其作用途径可能与阻断Cu2 + 或Fe2 + 诱导的自由基生成 ,保护内源性抗氧化物质SOD、VitE的活性有关。 Objective: To observe the reverse effect of Transferrin(Tf) on the oxidative modification of high density lipoprotein(HDL) , low density lipoprotein(LDL) and very low density lipoprotein(VLDL) induced by Cu^(2+) or Fe^(2+) in vitro. Methods: Human HDL, LDL and VLDL were prepared by one-step ultracentrifuge and oxidated by Cu^(2+) or Fe^(2+) at 37℃ for 6h. Then Tf(400μg/ml) was added to HDL, LDL and VLDL respectively for 8h incubation. The contents of MDA, Vitamin E and activity of superoxide dismutase (SOD) in HDL,LDL and VLDL were determined. Results:After incubated with Cu^(2+) or Fe^(2+), the MDA production of 3 kinds of lipoprotein increased significantly, but the level of Vit E and SOD declined(P<0.001).Compared with OX-HDL, OX-LDL, OX-VLDL group , Tf could markedly decrease MDA content meanwhile elevate Vit E level and SOD activity after 8h treatment(P<0.001). Conclusion: This result indicates that Tf can obviously reverse the oxidative modificaon of HDL,LDL and VLDL already induced both by Cu^(2+) or Fe^(2+). The mechanism may be associated with its ability of blocking free radical process and protecting endogenous anti-oxidation agents such as Vit E and SOD.
出处 《泸州医学院学报》 2004年第5期391-393,共3页 Journal of Luzhou Medical College
关键词 转铁蛋白 血浆脂蛋白 氧化修饰 动脉粥样硬化 Plasma Lipoprotein, Transferrin, Oxidative modification, Atherosclerosis
  • 相关文献

参考文献8

二级参考文献34

  • 1张林华,刘秉文.一次性密度梯度超速离心分离人血清脂蛋白[J].生物化学与生物物理学报,1989,21(3):257-260. 被引量:116
  • 2汪浩川,刘秉文.生长因子、癌基因与动脉平滑肌细胞增殖[J].生理科学进展,1994,25(1):48-53. 被引量:26
  • 3汪浩川,刘秉文,傅明德.人动脉平滑肌细胞贴块培养法[J].华西医科大学学报,1995,26(1):105-108. 被引量:35
  • 4Clarke MJ, Zhu F, Frasca DR. Non- platinum chermotherapeutic metallopharmaceuticals. Chem Rev 1999 ;99:2511.
  • 5Frasca DR, Gehrig LE, Clarke MJ. Cellular effects of transferrin coordinated to [ CI( NH3 ) 5 Ru ] Cl2 and cis - [ Cl2 ( NH3 ) 4 Ru ] Cl. J lnorg Biochem 2001 ;83:139.
  • 6Kratz F, Keppler BK, Hartmann M, Messori L, Berger MR. Comparison of the antiproliferative activity of two antitumor ruthenium ( Ⅲ )complexes with their apotransferrin and transferrin - bound forms in human clon cancer cell line. Metal- Based Drugs 1996 ;3:15.
  • 7Harding MM, Mokdsi G. Antitumour metallocenes : Structure - activity studies and interactions with biomolecules. Curr Med Chem 2000;7:1289.
  • 8Guo M, Sadler PJ. Competitive binding of the anticancer drug titanocene dichloride to N, N - ethylenebis - ( o - hydroxyphenylglycine )and adenosine triphosphate : a model for Ti iv uptake and release by transferrin. J Chem Soc Dalton Trans 2000;1:7.
  • 9Messori L, Orioli P, Banholzer V, Pals I, Zatta P. Formation of titanium( Ⅳ ) transferrin by reaction of human serum apotronsferrin with titanium complexes. FEBS Lett 1999 ;442:157.
  • 10Bernstein LR. Mechanisms of therapeutic activity for gallium. Pharmaco Rev 1998 ;50:665.

共引文献152

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部